resources

• about CSAM
  • bylaws
  • committees
  • CSAM staff
  • executive council
  • awards
• resources
  • buprenorphine info
  • NTP guideline
  • conference presentations
  • primary care physicians
  • links
  • medical education and research foundation
• newsletter
• public policy
  • public policy resources
  • current legislation
• membership info
• continuing medical education
• find CSAM physicians
• career center
• contact CSAM
• home

• Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment /Timothy Condon, PhD, Deputy Director, National Institute on Drug Abuse, Washington, DC
• Neurobiology of Addiction / David Presti, PhD, Professor of Neurobiology, Department of Molecular and Cell Biology, UC Berkeley
• The Genetic Basis for Vulnerability to Substance Abuse / George Uhl, MD, PhD, Director, Molecular Neurobiology Branch, National Institute on Drug Abuse
• The Latest in Medications Development / Francis Vocci, PhD, Director, Division of Treatment Research & Development, National Institute on Drug Abuse, Washington DC
• NIDA Treatment Principles / Peter Banys, MD, Director, Substance Abuse Programs, VA Medical Center, San Francisco; Associate Clinical Professor of Psychiatry UCSF
• Management of Psychiatric Co-Morbidities / John Tsuang, MD, Director, Dual Diagnosis Treatment Program, Harbor/UCLA Medical Center; Associate Professor of Medicine, UCLA
• Critical Role of 12-Step Programs / John Chappel, MD, Professor Emeritus, University of Nevada School of Medicine, Reno, NV
• Alcohol Abuse / Anthony Albanese, MD, Director, Chemical Dependency Division and Director, Hepatitis C Program, VA Medical Center, Mather, CA; Associate Clinical Professor of Medicine, UC Davis
• Nicotine Dependence: An Expanded Role for Addiction Medicine Physicians / Steven Schroeder, MD, Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF
• Understanding Benzodiazepines / Steve Juergens, MD, Assistant Clinical Professor of Psychiatry, University of Washington; Private Practice
• All About Club Drugs / Karen Miotto, MD, Associate Professor, Department of Psychiatry and Behavioral Sciences, UCLA School of Medicine
• Opiate Dependence / Andrew Saxon, MD, Director, Addictions Patient Care Line, Veterans Administration Puget Sound Health Care System; Associate Professor of Psychiatry and Behavioral Sciences, University of Washington
• Stimulants: Abuse and Treatment / Richard Rawson, PhD Associate Director of the UCLA Integrated Substance Abuse Programs; Associate Director, UCLA Department of Psychiatry
• Understanding Cannabis / Timmen Cermak, MD, Private Practice of Psychiatry and Addiction Psychiatry in San Francisco and Marin Counties; Medical Director, Henry Ohlhoff Programs, San Francisco
• Nicotine Dependence: Improving Your Treatment Skills / Judith Prochaska, PhD, MPH, Assistant Adjunct Professor, UC San Francisco Department of Psychiatry and Steven Fremont, MD, Associate Physician, UCSF Department of Psychiatry, Medical Director, Medical Director, Dual Diagnosis Inpatient Unit, Alta Bates, Summitt Medical Center, Berkeley
• Epidemiology of Drug Addiction / Jane Maxwell, PhD, Research Scientist, School of Social Work, University of Texas at Austin
• Special Populations -- Homeless / Brad Shapiro, M.D., Medical Director, OTOP/Ward 93 San Francisco General Hospital
• Understanding Infectious Diseases in Addicted Patients / Kristen Ochoa, MD, Director, LA Overdose Prevention Task Force
• Overview of Drug Testing Methodologies / Anthony Albanese, MD, Director, Chemical Dependency Division and Director, Hepatitis C Program, VA Medical Center Mather, CA, Associate Clinical Professor of Medicine, UC Davis

 

Addiction Medicine State of the Art 2005

• A Role of the Brain Stress Systems in the "Dark Side" of Addiction (PDF) / George F. Koob, PhD
• Stress and Addiction Relapse: Psychobiological Mechanisms and Clinical Implications (PDF) / Rajita Sinha, PhD
• Hormonal Responses to Acute and Chronic Stress: A Role for Comfort Food (PDF) / Mary Dallman, PhD
• Mechanisms of Food Craving and Drug Addiction: Similarities and Differences (PDF) / Dana M. Small, PhD
• Chronic Stress: Effects on Eating and Cell Aging (PDF) / Elissa Epel, PhD
• Smoking Impairs Recovery from Alcohol: New Evidence (PDF) / Timothy C. Durazzo, PhD
• The Endocannabinoid System and the Regulation of Pain and Emotion (PDF)/ Daniele Piomelli, PhD
• Cannabinoid CB1 Receptor Antagonists: The New Option in the Treatment of Obesity, Metabolic Syndrome and Addiction (PDF) / Daniela Cota, MD
• A Chronic Care Perspective (PDF) / A. Thomas McLellan, PhD
• Defining the Continuum (PDF) / Constance Weisner, DrPH, MSW
• DBT and the Art of Engagement (PDF) / Elisabeth P. Bellows, MD
• The Role of Public Health in Addiction Medicine (PDF) / Robert Brewer, MD
• Illicit Drug Use Among Adolescents (PDF) / Amy Khan, MD, MPH
• Community & School Based Interventions Update (PDF) / Jeffery Wilkins, MD
• Alcohol Markers (PDF) / Denise Greene, MD
• Provigil, Lunestra and Topamax (PDF) / Denise Greene, MD
• Connection Through Suffering (PDF) / Michael Kearney, MD
• Opioids and Pain Pathways (PDF) / Peggy Compton, RN, PhD
• Emerging Insights from Research Models of Pain and Addiction (PDF) / Christopher J. Evans, PhD

Dual Diagnosis (Pre-Conference Workshop)

 

 

• Neurobiology of Alcohol Dependence and Stimulant Abuse: Implications for Treatment Strategies (PDF) / Jeffery Wilkins M.D.
• Co-Morbid Substance Abuse and Severe Mental Illness (PDF) / John Tsuang, MD
• Co-Morbid Substance Abuse and Depression or Anxiety Disorders (PDF) / Romana Markvitsa M.D
• ADHD and Substance Abuse (PDF) / Henrik Zakari M.D.

Dialectical Behavior Therapy An Experiential Workshop on Engagement and Confrontation (Powerpoint) / Elisabeth P. Bellows, MD and Michael Hutchinson, LMFT (Pre-Conference Workshop)

 

Chronic Pain: Clinical Tools for the Addiction Medicine Specialist: Application to Fibromyalgia, Back Pain, and Headache (Pre-Conference Workshop)

• Introduction to the day / Karen Miotto, MD
• Neuroanatomy / Jodie Trafton, PhD
• Clinical Assessment from a Pain Management Perspective / Bill McCarberg, MD
• Assessment of Psychological Factors in Treatment of Chronic Pain / John McKellar, PhD
• Fibromyalgia: When it Hurst All Over: A 2005 Update / Stuart Silverman, MD
• Back Pain: Update / Bill McCarberg, MD
• Headache: Update / Philip O'Carroll, MD

 

Addiction Medicine Review Course 2004

• Co-Occurring Addiction and Severe Mental Disorders / Richard Ries, MD
• Co-Occurring Addiction and Mild/Moderate Mental Disorders / Richard Ries, MD
• Genetics of Alcoholism and Addiction / Marc Schuckit, MD
• Linking Science and Treatment in Addiction Medicine / Sean Koon, MD
• 12-Step Programs / Garrett O’Connor, MD
• Benzodiazepines / Mel Pohl, MD
• Infectious Diseases / Diana Sylvestre, MD
• Treatment of Dual Diagnosis Patients / John Tsuang, MD
• Stimulants / Richard Rawson, PhD
• Neonatal and Women's Issues / Carol Archie, MD
• The Family in Recovery / Sue Jackson, MS, MFT
• Medical Review Officer / David Smith, MD

• Opioids: Should Tolerance Affect our Management? -- Pamela Pierce Palmer, MD, PhD, Director, Pain Management Center, UCSF
• The Thin Edge of the Wedge: Acceptance, Change, and Behavior Therapy in the Treatment of Addiction -- Elisabeth Bellows, MD, Private Practice of Psychiatry, Menlo Park, CA
• The Impact of Research on the Care of Addicted Patients: A NIDA Update -- Nora Volkow, MD, Director, National Institute on Drug Abuse
• Looking for the Neural Basis of Motivation -- Howard Fields, MD, PhD, Director, Wheeler Center for the Neurobiology of Addiction, UCSF
• Is There a Common Neural Substrate for Analgesia and Reward? -- Robert W. Gear, DDS, PhD, Assistant Clinical Professor, Department of Oral and Maxillofacial Surgery, UCSF
• Forget it! The Role of Alpha-2 Agonists in Fear Conditioning -- M. Frances Davies, PhD, Research Associate and Director of Faculty Development, Stanford University VAPAHCS
• Medications Development for Treatment of Drug Abuse: A Path from Clinical Trial to Market -- Donald R. Wesson, MD, Consultant, CNS Medication Development; Chair ASAM Committee on Medications Development, Oakland, CA
• Advances in the Genetics of Addiction -- Raymond White, PhD, Director, Ernest Gallo Clinic & Research Center, UCSF
• Hot Topics in Neuroimaging Addictive Disorders -- Nora Volkow, MD, Director, National Institute on Drug Abuse
• Alcohol-Induced Brain Injury and its Reversal with Abstinence: Clinical Magnetic Resonance Studies -- Dieter J. Meyerhoff, Dr.rer.nat, Associate Professor of Radiology, UCSF; Senior Research Associate, VA Medical Center, SF
• Ibogaine Analogues: Drug Development for Addictive Disorders -- Stanley Glick, PhD, MD, Professor and Director, The Center for Neuropharmacology and Neuroscience, Albany Medical Center, Albany, NY
• Co-Occurring Disorders: Overview of Latest Research and Clinical Implications -- Douglas Ziedonis, MD, MPH, Director, Division of Addiction, Robert Wood Johnson Medical School, Piscataway, NJ
• Contingency Management of Disability Benefits for Severely Mentally Ill Persons with Substance Disorders -- Richard Ries, MD, Psychiatry, Dual Disorders Programs and Addiction Programs, Harborview Medical Center, Seattle, WA
• Bipolar Disorder and Substance Abuse: Impact and Treatment Implications-- Mark Frye, MD, Associate Professor of Psychiatry, David Geffen School of Medicine at UCLA; Director, UCLA, Bipolar Disorder Research Program, Los Angeles, CA
• Integrating 12-Step Spirituality, 21st Century Pharmacotherapy and Dual Diagnosis Concepts -- Garrett O'Connor, MD, Associate Clinical Professor of Psychiatry, UCLA; Consultant, Betty Ford Center, Rancho Mirage, CA
• Post-traumatic Stress Disorder in the Addicted: What We Know, What We Need to Know: An Interactive Workshop -- Elisa Triffleman, MD, Senior Research Scientist, The Public Health Institute, Oakland, CA; Research Affiliate, Yale University School of Medicine
• Integrating Dual Recovery Therapy and Medications for Co-Occurring Disorders -- Douglas Ziedonis, MD, MPH, Director, Division of Addiction, Robert Wood Johnson Medical School, Piscataway, NJ
• Dialectical Behavioral Therapy in the Treatment of Bulimia and Binge Eating Disorder: Research and Practical Applications -- Deborah Safer, MD, Associate Director of Residency Training Program in Psychiatry, Staff Psychiatrist and Research Scientist, Stanford University, Palo Alto
• Treatment Needs of Women with Co-Occurring Disorders -- Joan Zweben, PhD, Exec. Dir., 14th St. Clinic & East Bay Community Recovery Project, Oakland; Clinical Prof. of Psychiatry, UCS
• Why Are So Many Dually Disordered Patients So Over-Medicated and What Are the Implications of This? -- Richard Ries, MD, Prof. of Psychiatry Univ. of Washington Medical School, Director of Outpatient Psychiatry, Dual Disorders Programs and Addiction Programs, Harborview Medical Center, Seattle
• Culture and Infection: Understanding Risk-Taking Among Heroin Users in San Francisco -- Daniel H. Ciccarone, MD, MPH, Assistant Professor, Department of Family and Community Medicine, and Department of Anthropology, History and Social Medicine, UCSF